GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Brighten Optix Corp (ROCO:6747) » Definitions » Capex-to-Revenue

Brighten Optix (ROCO:6747) Capex-to-Revenue : 0.02 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Brighten Optix Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Brighten Optix's Capital Expenditure for the three months ended in Mar. 2024 was NT$-4.55 Mil. Its Revenue for the three months ended in Mar. 2024 was NT$190.13 Mil.

Hence, Brighten Optix's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.02.


Brighten Optix Capex-to-Revenue Historical Data

The historical data trend for Brighten Optix's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brighten Optix Capex-to-Revenue Chart

Brighten Optix Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.02 0.04 0.11 0.11 0.06

Brighten Optix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.12 0.10 0.01 0.02

Competitive Comparison of Brighten Optix's Capex-to-Revenue

For the Medical Devices subindustry, Brighten Optix's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brighten Optix's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Brighten Optix's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Brighten Optix's Capex-to-Revenue falls into.



Brighten Optix Capex-to-Revenue Calculation

Brighten Optix's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-46.145) / 747.3
=0.06

Brighten Optix's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-4.549) / 190.13
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brighten Optix  (ROCO:6747) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Brighten Optix Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Brighten Optix's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Brighten Optix (ROCO:6747) Business Description

Traded in Other Exchanges
N/A
Address
No. 150, Chengde Road, 6th Floor-1, Section 4, Shilin District, Taipei, TWN, 111
Brighten Optix Corp is a Taiwan-based company engaged in the manufacturing of contact lenses. The product offerings of the company include Corneal plastic film, Hard contact lenses, Customized soft contact lenses, Hard potion, and Other ancillary products.

Brighten Optix (ROCO:6747) Headlines

No Headlines